ConductScience.org, home

Paper42931991PubMed

At the Crossroads of Synapses and Signaling: The Role of LRRK2 in Neuronal Communication.

Di Iacovo A and 5 others. Cell Mol Neurobiol, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. At the Crossroads of Synapses and Signaling: The Role of LRRK2 in Neuronal Communication. Papers, record 42931991. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42931991

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
At the Crossroads of Synapses and Signaling: The Role of LRRK2 in Neuronal Communication.
Journal
Cell Mol Neurobiol
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-29

Source PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Major topic
Signal TransductionMajor topic
SynapsesMajor topic
NeuronsMajor topic
Cell CommunicationMajor topic
Animals
Humans
Synaptic Transmission
Protein Transport

Source PubMed

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,663,853PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins.Elife2019https://conductscience.org/library/papers/31663853PubMed
230,647,193Rab29 activation of the Parkinson's disease-associated LRRK2 kinase.EMBO J2019https://conductscience.org/library/papers/30647193PubMed
332,873,436Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease.Neurobiol Aging2021https://conductscience.org/library/papers/32873436PubMed
424,874,075Mutant LRRK2 enhances glutamatergic synapse activity and evokes excitotoxic dendrite degeneration.Biochim Biophys Acta2014https://conductscience.org/library/papers/24874075PubMed
534,322,000A Computational Study of Astrocytic GABA Release at the Glutamatergic Synapse: EAAT-2 and GAT-3 Coupled Dynamics.Front Cell Neurosci2021https://conductscience.org/library/papers/34322000PubMed
632,256,311The Emerging Functions of LRRK2 and Rab GTPases in the Endolysosomal System.Front Neurosci2020https://conductscience.org/library/papers/32256311PubMed
732,523,507"LRRK2: Autophagy and Lysosomal Activity".Front Neurosci2020https://conductscience.org/library/papers/32523507PubMed
838,968,112Parkinson's-linked LRRK2-G2019S derails AMPAR trafficking, mobility, and composition in striatum with cell-type and subunit specificity.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38968112PubMed
933,554,649Influence of glutamate and GABA transport on brain excitatory/inhibitory balance.Exp Biol Med (Maywood)2021https://conductscience.org/library/papers/33554649PubMed
1020,842,175Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.Nat Rev Neurosci2010https://conductscience.org/library/papers/20842175PubMed
1138,313,055Lysosomal stress drives the release of pathogenic α-synuclein from macrophage lineage cells via the LRRK2-Rab10 pathway.iScience2024https://conductscience.org/library/papers/38313055PubMed
1233,674,612Dynamic control of the dopamine transporter in neurotransmission and homeostasis.NPJ Parkinsons Dis2021https://conductscience.org/library/papers/33674612PubMed
1330,209,220LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/30209220PubMed
1430,837,320LRRK2 links genetic and sporadic Parkinson's disease.Biochem Soc Trans2019https://conductscience.org/library/papers/30837320PubMed
1539,655,696The kinase LRRK2 is required for the physiological function and expression of the glial glutamate transporter EAAT2 (SLC1A2).J Neurochem2025https://conductscience.org/library/papers/39655696PubMed
1632,997,602Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases.Annu Rev Pharmacol Toxicol2021https://conductscience.org/library/papers/32997602PubMed
1726,365,310LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase.Nat Commun2015https://conductscience.org/library/papers/26365310PubMed
1826,269,629The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippocampus.J Neurosci2015https://conductscience.org/library/papers/26269629PubMed
1922,420,899Astrocytes convert network excitation to tonic inhibition of neurons.BMC Biol2012https://conductscience.org/library/papers/22420899PubMed
2023,395,371RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.Neuron2013https://conductscience.org/library/papers/23395371PubMed

See all 71 references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42931991

GET https://conductscience.org/api/papers/v1/42931991/references?page=2